Invited commentary: Human papillomavirus infection and risk of cervical precancerusing the right methods to answer the right questions

American Journal of Epidemiology

Volumn 171, Issue 2, 2010, Pages 164-168

  Franco, Eduardo L ^a   Tota, Joseph ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Cytology; Measurement error; Misclassification; Papillomavirus infections; Uterine cervical neoplasms; Vaginal smears

Indexed keywords

CANCER CLASSIFICATION; CANCER EPIDEMIOLOGY; NOTE; PRECANCER; UTERINE CERVIX CANCER; VAGINA SMEAR; VIRUS INFECTION; WART VIRUS;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 73949141736     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp392     Document Type: Note

References (25)

1. Franco EL, Olsen J, Saracci R, et al. Epidemiology's contributions to a Nobel Prize recognition. Epidemiology. 2009; 20(5):632-634.
2. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst. 1993;85(12):958-964.
3. Franco EL. The sexually transmitted disease model for cervical cancer: incoherent epidemiologic findings and the role of misclassification of human papillomavirus infection. Epidemiology. 1991;2(2):98-106.
4. Castle PE, Schiffman M, Wheeler CM, et al. Impact of improved classification on the association of human papilloma-virus with cervical precancer. Am J Epidemiol. 2010;171(2): 155-163.
5. Franco EL. Statistical issues in human papillomavirus testing and screening. Clin Lab Med. 2000;20(2):345-367.
6. Human papillomavirus testing for triage of women with cy-tologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. J Natl Cancer Inst. 2000;92(5):397-402.
7. Solomon D, Schiffman M, Tarone R, et al. Comparison of three management strategies for patients with atypical squa-mous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 2001;93(4):293-299. (Pubitemid 32219816)
8. Wright TC Jr., Schiffman M. Adding a test for human papil-lomavirus DNA to cervical-cancer screening. N Engl J Med. 2003;348(6):489-490
9. International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1060-1069.
10. Meanwell CA, Cox MF, Blackledge G, et al. HPV 16 DNA in normal and malignant cervical epithelium: implications for the aetiology and behaviour of cervical neoplasia. Lancet. 1987; 1(8535):703-707.
11. Reeves WC, Brinton LA, García M, et al. Human papilloma-virus infection and cervical cancer in Latin America. N Engl J Med. 1989;320(22):1437-1441. (Pubitemid 19143707)
12. Donnan SP, Wong FW, Ho SC, et al. Reproductive and sexual risk factors and human papilloma virus infection in cervical cancer among Hong Kong Chinese. Int J Epidemiol. 1989; 18(1):32-36.
13. Peng HQ, Liu SL, Mann V, et al. Human papillomavirus types 16 and 33, herpes simplex virus type 2 and other risk factors for cervical cancer in Sichuan Province, China. Int J Cancer. 1991;47(5):711-716.
14. Kanetsky PA, Mandelblatt J, Richart R, et al. Risk factors for cervical cancer in a black elderly population: preliminary findings. Ethn Dis. 1992;2(4):337-342.
15. Muñoz N, Bosch FX, de Sanjosé S, et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer. 1992;52(5):743-749.
16. Shen CY, Ho MS, Chang SF, et al. High rate of concurrent genital infections with human cytomegalovirus and human papillomaviruses in cervical cancer patients. J Infect Dis. 1993; 168(2):449-452.
17. Eluf-Neto J, Booth M, Muñoz N, et al. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer. 1994;69(1): 114-119.
18. Asato T, Nakajima Y, Nagamine M, et al. Correlation between the progression of cervical dysplasia and the prevalence of human papillomavirus. J Infect Dis. 1994;169(4): 940-941.
19. Herrero R, Hildesheim A, Bratti C, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst. 2000;92(6): 464-474.
20. Thomas DB, Qin Q, Kuypers J, et al. Human papillomaviruses and cervical cancer in Bangkok. II. Risk factors for in situ and invasive squamous cell cervical carcinomas. Am J Epidemiol. 2001;153(8):732-739. (Pubitemid 32319699)
21. Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518-527. (Pubitemid 36159887)
22. Tidy JA, Parry GC, Ward P, et al. High rate of human papil-lomavirus type 16 infection in cytologically normal cervices [letter]. Lancet. 1989;1(8635):434.
23. Franco E, Villa L, Rohan T, et al. Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Ludwig-McGill Study Group. Rev Panam Salud Pub-lica. 1999;6(4):223-233.
24. Schlecht NF, Kulaga S, Robitaille J, et al. Persistent human papillomavirus infection as a predictor of cervical intraepi-thelial neoplasia. JAMA. 2001;286(24):3106-3114.
25. Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med. 2009;360(14): 1385-1394.